Prognostic impact of the TP53 rs1625895 polymorphism in DLBCL patients

E-ISSN： 1365-2141|169|1|32-35

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.169, Iss.1, 2015-04, pp. : 32-35

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

TP53 Codon 72 Polymorphism in Classic, Endemic and Epidemic Kaposi’s Sarcoma in African and Caucasian Patients

Oncology, Vol. 77, Iss. 5, 2009-11 ,pp. : 328-334

Karger

Access to resources Recommend Favorite

MDM2 rs2279744 and TP53 rs1042522 Polymorphisms Associated with Etoposide- and Cisplatin-Induced Grade III/IV Neutropenia in Chinese Extensive-Stage Small-Cell Lung Cancer Patients

Oncology Research and Treatment, Vol. 37, Iss. 4, 2014-03 ,pp. : 176-180

Karger

Access to resources Recommend Favorite

Tumoral TP53 and/or CDKN2A alterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: A report from the Children's Oncology Group

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 5, 2015-05 ,pp. : 759-765

John Wiley & Sons Inc

Access to resources Recommend Favorite

TP53 Gene Mutation, an Unfavorable Prognostic Factor for Malignant Lymphomas in Autoimmune Diseases

Oncology, Vol. 69, Iss. 2, 2005-09 ,pp. : 175-183

Karger

Access to resources Recommend Favorite

TP53 overexpression is an independent adverse prognostic factor in de novo myelodysplastic syndromes with fibrosis

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 171, Iss. 1, 2015-10 ,pp. : 91-99

John Wiley & Sons Inc

Access to resources Recommend Favorite